5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
Try a substance, brand, or product name…
Cart 0
€85,00 more for free shipping
No products in the cart.
Injectable Steroids
SP Trenbolone Forte (Trenbolone Enanthate) 200 mg SP Laboratories
SP Laboratories
€85,00
In Stock(100 available)
SP Trenbolone Forte (Trenbolone Enanthate) 200 mg SP Laboratories (200 mg) — Trenbolone Acetate is the compound that separates recreational users from dedicated athletes. With five times the anabolic potency…
100 in stock
5+−10%
10+−15%Best price
Third-Party Lab ReportHPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
This SP Laboratories tren E at 200 mg delivers trenbolone’s full mechanism (5× androgen-receptor affinity, glucocorticoid binding, nutrient partitioning) with a longer release profile than acetate. Pair with testosterone at TRT dose minimum.
Key Benefits
Same receptor action as tren acetate — long ester for less pinning
Twice-weekly injections produce flatter plasma than acetate EOD
Cleaner PIP than acetate — cleaner injection experience
Same side-effect burden as ace — not a “softer” tren
Each unit dosed at 200 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 200–400 mg/week split Mon/Thu. Steady-state requires 4–5 weeks of consistent dosing. Cycles 12–14 weeks to exploit the stable pharmacokinetic profile.
How It Works
19-nor trenbolone esterified to enanthoic acid. At the AR identical to acetate — ester changes only release kinetics, not biological activity. Progestagenic potential unchanged. Nutrient-partitioning profile unchanged.
Pharmacokinetics
Plasma half-life approximately 7 days. Twice-weekly pinning gives flat serum levels. Post-cycle clearance slower than acetate: wait 14 days after last pin before starting SERM-based PCT.
Potential Side Effects
Same side-effect burden as tren ace: sleep disruption, aggression, CV stress, prolactin rise. The longer ester doesn’t soften the compound — only spreads the same load over a gentler plasma curve. Caber 0.25 mg 2×/week. Bloodwork at week 6.
Cycle & Stacking Guide
Recomp and off-season strength cycles 12–14 weeks. Pair test E 400 mg/week + tren E 300 mg/week. Still requires caber, still demands bloodwork and sleep discipline. Not a beginner compound.
Manufacturer Notes
SP Laboratories is a long-established Moldovan producer. Their formulations are standardised around 100, 150, and 200 mg/ml concentrations — useful when calibrating injection volumes during a cycle.
Storage & Handling
Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.
Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead
19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
We use cookies for essential site functionality and — with your consent — for analytics and marketing. You can accept all, reject non-essential, or configure. Privacy Policy
Reviews
There are no reviews yet.